Medtronic 2012 Annual Report Download - page 23

The charts below set forth net sales of our Spinal products as a percentage of our total net sales for each
of the last three fiscal years:
Customers and Competitors
The primary medical specialists who use our Spinal products are spinal surgeons, orthopedic surgeons,
neurosurgeons, and interventional radiologists. Competitors in this business include DePuy Spine, Inc.,
Synthes, Inc., Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Zimmer, Inc., Alphatec Spine, Inc.,
Orthofix International N.V., Biomet, Inc., and over 200 smaller competitors and physician-owned companies.
Johnson & Johnson, the parent company for DePuy Spine, Inc., acquired Synthes, Inc. in June 2012.
Neuromodulation
Our Neuromodulation business develops, manufactures, and markets medical devices for the treatment
of chronic pain, movement disorders, psychological disorders, and urological, fecal, and gastroenterological
disorders.
The following are the principal products offered by our Neuromodulation business:
Neurostimulators for Chronic Pain. Spinal cord stimulation uses a surgically implanted medical
device, similar to a cardiac pacemaker, to deliver mild electrical signals to the epidural space. We have the
largest portfolio of neurostimulation systems in the industry, including rechargeable and non-rechargeable
devices and a large selection of leads used to treat chronic back and leg pain. Our portfolio of products
includes the RestoreSensor (rechargeable), with our proprietary AdaptiveStim technology, as well as the
RestoreULTRA (rechargeable), RestoreADVANCED (rechargeable), and PrimeADVANCED (non-
rechargeable) neurostimulation systems.
Implantable Drug Delivery Systems. The SynchroMed II Programmable Infusion System delivers
small quantities of drug directly into the intrathecal space surrounding the spinal cord. These devices are
used to treat chronic, intractable pain and severe spasticity associated with cerebral palsy, multiple sclerosis,
spinal cord and traumatic brain injuries, and stroke.
Deep Brain Stimulation (DBS) Systems. DBS uses a surgically implanted medical device, similar to
a cardiac pacemaker, to deliver carefully controlled electrical stimulation to precisely targeted areas in the
brain. It works by electrically stimulating specific structures that control movement and muscle function.
DBS is used to treat the symptoms of movement disorders such as Parkinson’s disease, epilepsy (certain
countries outside the U.S. only), essential tremor, and dystonia, as well as psychiatric disorders such as
obsessive-compulsive disorder. Our family of Activa Neurostimulators for DBS includes Activa SC (single-
channel primary cell), Activa PC (dual channel primary cell), and Activa RC (dual channel rechargeable).
Urology, Fecal, & Gastroenterology Devices. Sacral nerve stimulation uses a surgically implanted
medical device, similar to a cardiac pacemaker, to offer long-term control of urinary control and bowel
control symptoms through modulation of the nerve activity by focusing on the nerves that control the pelvic
floor and lower urinary tract. Our therapeutic portfolio for urology and gastroenterology includes the
InterStim Therapy System, which treats the symptoms of overactive bladder, urinary retention, and chronic
fecal incontinence, and the Enterra Therapy System for the treatment of chronic nausea and vomiting caused
by gastroparesis of diabetic or idiopathic origin for drug refractory patients.
6
Spinal
$3,267
All Other
$12,917
Fiscal Year 2012
(dollars in millions)
Spinal
$3,414
All Other
$12,094
Fiscal Year 2011
(dollars in millions)
Spinal
$3,500
All Other
$11,892
Fiscal Year 2010
(dollars in millions)
23%
77%
22%
78%
80%
20%